Articles for category: Most Popular

Russ Cohen

Does MercadoLibre Stock Still Has Room To Run?

MercadoLibre Inc (NASDAQ: MELI), often dubbed the “Amazon of Latin America,” operates the region’s largest online marketplace—and it’s been steadily gaining market share for the past three years. Like Amazon (NASDAQ: AMZN) or eBay (NASDAQ: EBAY), it sells everything from electronics to apparel to household goods. But a more complete comparison would include PayPal (NASDAQ: ...

Russ Cohen

Synopsys (SNPS) Is Considered a Good Investment by Brokers: Is That True?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock’s price, do they really matter? Before we discuss the reliability of brokerage recommendations and how to use ...

Russ Cohen

Will Tesla See a Second Consecutive Year of Delivery Decline?

Tesla TSLA is facing a growing concern that can no longer be brushed aside — weakening deliveries. After its first-ever annual delivery decline in 2024, 2025 started on a rough note. Sales have fallen across key markets, with Europe leading the downturn. Deliveries in Q1 fell 13% year over year. In Q2, deliveries fell another 13.4% ...

Russ Cohen

Noteworthy Wednesday Option Activity: MSTR, AAPL, NKE

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in MicroStrategy Inc. (Symbol: MSTR), where a total volume of 687,757 contracts has been traded thus far today, a contract volume which is representative of approximately 68.8 million underlying shares (given that every 1 contract represents 100 underlying ...

Russ Cohen

5 Top Tech Stocks to Buy Right Now

Technology stocks have helped lead the market higher over the past several years, and with the advent of artificial intelligence (AI), they look poised to continue to lead the way. Let’s look at five top tech stocks catching the AI tailwinds that you might want to consider buying right now. Where to invest $1,000 right ...

Russ Cohen

Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump

Shares of Elite Pharmaceuticals, Inc. ELTP have lost 15.7% since the company reported its earnings for the fiscal year ended March 31, 2025. This compares to the S&P 500 Index’s 0.9% gain over the same time frame. Over the past month, however, the stock rebounded with an increase of 7.2%, outperforming the S&P 500’s 4.4% ...